🔎 Trials Near Me

Home › NCT06869512

Cooperative Extension and Cancer Survivorship

Recruiting

Cooperative Extension and Cancer Survivorship: Supportive Care Via Cooperative Extension Services (SUCCESS)

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Previous adult-diagnosed cancer
* Post active cancer treatment
* No current active treatment, hormonal therapy permitted
* Ability to get to group sessions
* In Oklahoma

Exclusion Criteria:

* Current palliative or hospice care
* Surgical or medical history that precludes participation
* Positive screen on the Physical Activity Readiness Questionnaire+ (PAR-Q+) without a doctor's note approving study participation

About the study

The goal of this clinical trial is to learn if a cancer survivor program, delivered via Cooperative Extension, is feasible and if it can improve health outcomes in cancer survivors who are post-active treatment.

Aim 1: Evaluate the feasibility and acceptability of SUCCESS. Hypothesis 1: SUCCESS will be feasible and acceptable as evidenced by delivery of the intervention among Educators (implementation), including in agreement with the curriculum in Phase 1 (fidelity) with \>85% attendance (demand) among participants with \>80% rating the intervention as acceptable or highly acceptable on 5-point Likert-type scale (acceptability).

Aim 2: Determine the preliminary efficacy of SUCCESS for improving HRQOL (primary outcome) and other psychosocial and health-related endpoints (e.g., financial toxicity) (secondary outcomes). Hypothesis 2: Compared to matched controls, adults LWBC who complete SUCCESS will have significant improvements in HRQOL per the PROMIS Global Health v1.2 at follow-up (i.e., after 6 weeks).

Aim 3: Examine changes in conserved transcriptional response to adversity (CTRA) gene expression in a subset of interventions participants at follow-up. Hypothesis 3: Adults LWBC who complete SUCCESS will experience significant CTRA down-regulation.

This is a single arm trial and there is no comparison group.

Participants will be asked to do survey- and Zoom-based data collection before and after completing the 6-week program.

What is being tested

Sponsor: University of Oklahoma · Participants: 80 · Started: Feb 24, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06869512

Locations in the U.S.

OklahomaUniversity of Oklahoma, Tulsa

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.